查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1600933

人源类器官市场：按产品、可用性、应用和最终用户划分 - 2025-2030 年全球预测

Human Organoids Market by Product (Colorectal, Heart, Kidney), Usability (Customizable Products, Ready to Use Products), Application, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年人源类器官市场规模预计为5.9484亿美元，预计2024年将达到7.0334亿美元，复合年增长率为19.94%，到2030年将达到21.2491亿美元。

人源类器官是干细胞源性器官的3D微型化版本，模仿真实器官的功能和结构。这种尖端模型处于生物学和技术的交叉点，在人类疾病理解、药物开发和个人化医疗方面带来了前所未有的进步。对人源类器官的需求不断增长，因为它们能够提供比传统 2D 培养更准确的体外模型，可用于治疗复杂的人类特异性感染疾病、癌症和神经退化性疾病的研究。从那时起，它的应用范围扩大到包括製药、生物技术工业、学术研究和再生医学。主要最终用户包括製药商、学术研究机构和医院。

主要市场统计
基准年[2023] 5.9484亿美元
预测年份 [2024] 7.0334亿美元
预测年份 [2030] 21.2491亿美元
复合年增长率（%） 19.94%

该市场的成长受到干细胞技术持续进步、个人化医疗需求不断增长以及政府资助研究倡议的强烈影响。此外，COVID-19 大流行凸显了需要更好的人类特异性模型来研究病毒感染，从而使市场受益。类器官技术在慢性病建模、个人化药物筛检和毒性测试方面的扩展存在着巨大的商机，为生物技术公司和学术机构之间的策略联盟铺平了道路。

然而，开发成本高、维持 3D 培养的技术复杂性、使用干细胞的伦理考量以及缺乏标准化通讯协定等挑战正在阻碍市场扩张。透过全行业合作和监管发展来解决这些限制可以促进成长。基于 CRISPR 的基因编辑、晶片类器官平台以及与人工智慧整合进行巨量资料分析等创新代表了研究和开发的肥沃领域。在快速的技术进步和策略伙伴关係关係的推动下，市场的本质仍然是动态和竞争的。公司应专注于确保类器官可重复性和扩充性的技术，并加强多学科团队之间的合作，以利用不同的专业知识，从而加强其市场地位并利用新的机会。

市场动态：揭示快速发展的人类类器官市场的关键市场洞察

供需的动态交互作用正在改变人源类器官市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助消费行为及其对製造业的影响。

  • 市场驱动因素
    • 迫切需要开发动物实验模型的替代品
    • 越来越关注改善疾病模型和药物发现
  • 市场限制因素
    • 缺乏熟练劳动力
  • 市场机会
    • 人源类器官开发的研究经费与资本投资大幅增加
    • 将人源类器官应用于生物计算的可能性
  • 市场挑战
    • 当前类器官技术的问题

波特的五力：驾驭人类类器官市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解外部对人源类器官市场的影响

外部宏观环境因素在塑造人源类器官市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解人源类器官市场的竞争状况

对人源类器官市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵人源类器官市场供应商的绩效评估

FPNV定位矩阵是评估人源类器官市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。四个象限清楚且准确地划分供应商，帮助使用者辨识最能满足其策略目标的合作伙伴和解决方案。

本报告提供了涵盖关键重点领域的全面市场分析：

1. 市场渗透率：对当前市场环境的详细回顾，包括行业主要企业的大量资料。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 迫切需要开发替代动物实验模型。
      • 越来越关注改善疾病模型和发现新药
    • 抑制因素
      • 缺乏熟练劳动力
    • 机会
      • 人源类器官开发的研究经费与资本投资大幅增加
      • 人源类器官在生物计算的潜在应用
    • 任务
      • 与当前类器官技术相关的问题
  • 市场区隔分析
    • 产品：发现肝臟类器官在药理学和毒理学研究中的关键作用
    • 脂溶性：增加人源类器官在药物毒性和功效测试中的采用，以改善病患照护和安全
    • 应用：增加使用可客製化产品，使研究人员能够客製化类器官培养物以满足特定需求
    • 最终用户：学术和研究机构对人源类器官的需求日益增长，以识别新的药物标靶并了解疾病进展。
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章 人类源性类器官市场：副产品

  • 冒号
  • 心
  • 肾
  • 肝
  • 胰臟

第七章 人源类器官市场：使用性别

  • 可客製化产品
  • 即用型产品

第八章 人源类器官市场：依应用分类

  • 发育生物学
  • 疾病病理学
  • 药物毒性及药效测试
  • 个人化医疗
  • 再生医学

第 9 章 人类源性类器官市场：依最终使用者分类

  • 学术研究所
  • 临床研究所
  • 製药和生物技术公司

第10章美洲人源类器官市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太地区人源类器官市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲的人源类器官市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Sinai Health 对培养类器官的 1000 万美元投资将改变疾病调查和药物发现
    • 合作伙伴关係推进药物开发中的心臟安全测试：ATCC 和 Tissue Dynamics 合作
    • 利用人类肝类器官技术提高药物安全性：CuSTOM 与丹纳赫公司之间的创新合作
    • 使用干细胞衍生的脑类器官进行神经退化性疾病建模的革命性进展
    • 透过开放用于下一代疾病建模的最先进的类器官设施来推进精准医学
    • 罗氏的革命性推出：人类生物学研究所利用类器官技术推进医学研究
    • 罗氏在巴塞尔建立人类生物学研究所，透过研究类器官和人体模型系统彻底改变药物发现
    • 国家科学基金会工程办公室的新前沿：从类器官智慧到客製化学习
    • Molecular Devices 与 HUB Organoids 合作推进 3D 生物技术
    • 创新药物发现：Molecular Devices 与 HUB Organoids 建立策略伙伴关係

公司名单

  • 3Dnamics Inc.
  • AIVITA Biomedical, Inc.
  • BICO Group AB
  • Bio-Techne Corporation
  • BioIVT LLC
  • BrainZell
  • Cannex Scientific, Inc.
  • CN Bio Innovations Limited
  • Corning Incorporated
  • DefiniGEN Limited
  • F. Hoffmann-La Roche Ltd.
  • HeartBeat.bio AG
  • Herophilus
  • HUB Organoids BV
  • InSphero AG
  • Kirkstall Ltd.
  • Merck KGaA
  • Miltenyi Biotec BV & CO. KG
  • Mimetas BV
  • Molecular Devices, LLC by Danaher Corporation
  • Neurxstem Inc.
  • Organovo Holdings Inc.
  • Pandorum Technologies Pvt. Ltd.
  • PerkinElmer, Inc.
  • PRIMACYT Cell Culture Technology GmbH
  • Rumi Scientific, Inc.
  • STEMCELL Technologies Canada Inc.
  • SUN bioscience SA.
  • Takara Holdings Inc.
  • Thermo Fisher Scientific Inc.
  • ZenBio, Inc.
Product Code: MRR-DD6333AE58DD

The Human Organoids Market was valued at USD 594.84 million in 2023, expected to reach USD 703.34 million in 2024, and is projected to grow at a CAGR of 19.94%, to USD 2,124.91 million by 2030.

Human organoids are three-dimensional, miniaturized versions of organs derived from stem cells, mimicking actual organ function and structure. These cutting-edge models represent an intersection of biology and technology, offering unprecedented advancements in understanding human diseases, drug development, and personalized medicine. The increasing necessity for human organoids stems from their capability to provide more accurate in vitro models than traditional 2D cultures, aiding research into complex human-specific infections, cancer, and neurodegenerative diseases. Subsequently, their applications span pharmaceutical and biotechnology industries, academic research, and regenerative medicine. Key end-users include drug manufacturers, academic and research institutes, and hospitals.

KEY MARKET STATISTICS
Base Year [2023] USD 594.84 million
Estimated Year [2024] USD 703.34 million
Forecast Year [2030] USD 2,124.91 million
CAGR (%) 19.94%

The market's growth is strongly influenced by continuous advancements in stem cell technologies, increasing demand for personalized medicine, and government funding supporting research initiatives. Moreover, the COVID-19 pandemic underscored the demand for better human-specific models to study viral infections, benefiting the market. Profound opportunities exist in the expansion of organoid technology for chronic disease modeling, personalized drug screening, and toxicity testing, creating avenues for strategic collaborations between biotech firms and academic institutions.

Nevertheless, challenges such as high development costs, technical complexities in 3D culture maintenance, ethical considerations regarding stem cell usage, and a lack of standardized protocols hinder market expansion. Addressing these limitations through industry-wide collaborations and regulatory advancements could drive growth. Innovations including CRISPR-based genetic editing, organoid-on-a-chip platforms, and integration with artificial intelligence for big data analysis represent fertile areas for research and development. The nature of the market remains dynamic and competitive, driven by rapid technological advancements and strategic partnerships. Businesses should focus on investing in technology that ensures reproducibility and scalability of organoids, and on enhancing collaboration between multidisciplinary teams to leverage varied expertise, thereby reinforcing their market position and capitalizing on emerging opportunities.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Human Organoids Market

The Human Organoids Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • High need for developing alternatives for animal testing models
    • Rising focus toward improving disease models and drug discovery
  • Market Restraints
    • Limited availability of skilled workforce
  • Market Opportunities
    • Significant increase in research funding and capital investments for the development of human organoids
    • Potential application of human organoids for biocomputing
  • Market Challenges
    • Issues related to current organoid technology

Porter's Five Forces: A Strategic Tool for Navigating the Human Organoids Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Human Organoids Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Human Organoids Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Human Organoids Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Human Organoids Market

A detailed market share analysis in the Human Organoids Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Human Organoids Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Human Organoids Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Human Organoids Market, highlighting leading vendors and their innovative profiles. These include 3Dnamics Inc., AIVITA Biomedical, Inc., BICO Group AB, Bio-Techne Corporation, BioIVT LLC, BrainZell, Cannex Scientific, Inc., CN Bio Innovations Limited, Corning Incorporated, DefiniGEN Limited, F. Hoffmann-La Roche Ltd., HeartBeat.bio AG, Herophilus, HUB Organoids B.V., InSphero AG, Kirkstall Ltd., Merck KGaA, Miltenyi Biotec B.V. & CO. KG, Mimetas BV, Molecular Devices, LLC by Danaher Corporation, Neurxstem Inc., Organovo Holdings Inc., Pandorum Technologies Pvt. Ltd., PerkinElmer, Inc., PRIMACYT Cell Culture Technology GmbH, Rumi Scientific, Inc., STEMCELL Technologies Canada Inc., SUN bioscience SA., Takara Holdings Inc., Thermo Fisher Scientific Inc., and ZenBio, Inc..

Market Segmentation & Coverage

This research report categorizes the Human Organoids Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Colorectal, Heart, Kidney, Liver, and Pancreas.
  • Based on Usability, market is studied across Customizable Products and Ready to Use Products.
  • Based on Application, market is studied across Developmental Biology, Disease Pathology, Drug Toxicity & Efficacy Testing, Personalized Medicine, and Regenerative Medicine.
  • Based on End-User, market is studied across Academic & Research Institutes, Clinical Research Organizations, and Pharmaceutical & Biotechnology Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, Maryland, Massachusetts, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. High need for developing alternatives for animal testing models
      • 5.1.1.2. Rising focus toward improving disease models and drug discovery
    • 5.1.2. Restraints
      • 5.1.2.1. Limited availability of skilled workforce
    • 5.1.3. Opportunities
      • 5.1.3.1. Significant increase in research funding and capital investments for the development of human organoids
      • 5.1.3.2. Potential application of human organoids for biocomputing
    • 5.1.4. Challenges
      • 5.1.4.1. Issues related to current organoid technology
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Emerging crucial role of liver organoids in pharmacology and toxicology studies
    • 5.2.2. Application: Increasing adoption of human organoids in drug toxicity and efficacy testing to improve patient care and safety
    • 5.2.3. Usability: Increasing usage of customizable products that allow researchers to tailor organoid cultures to their specific needs
    • 5.2.4. End-User: Rising need for human organoids across academic & research institutions for identifying novel drug targets and understanding disease progression
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Human Organoids Market, by Product

  • 6.1. Introduction
  • 6.2. Colorectal
  • 6.3. Heart
  • 6.4. Kidney
  • 6.5. Liver
  • 6.6. Pancreas

7. Human Organoids Market, by Usability

  • 7.1. Introduction
  • 7.2. Customizable Products
  • 7.3. Ready to Use Products

8. Human Organoids Market, by Application

  • 8.1. Introduction
  • 8.2. Developmental Biology
  • 8.3. Disease Pathology
  • 8.4. Drug Toxicity & Efficacy Testing
  • 8.5. Personalized Medicine
  • 8.6. Regenerative Medicine

9. Human Organoids Market, by End-User

  • 9.1. Introduction
  • 9.2. Academic & Research Institutes
  • 9.3. Clinical Research Organizations
  • 9.4. Pharmaceutical & Biotechnology Companies

10. Americas Human Organoids Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Human Organoids Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Human Organoids Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Transforming Disease Research and Drug Discovery with Sinai Health's USD 10 Million Investment in Lab-Grown Organoids
    • 13.3.2. Partnership Advances Cardiac Safety Testing in Drug Development: ATCC and Tissue Dynamics Collaboration
    • 13.3.3. Advancing Drug Safety with Human Liver Organoid Technology: CuSTOM and Danaher Corporation's Innovative Collaboration
    • 13.3.4. Revolutionary Advancements in Neurodegenerative Disease Modeling Through Stem Cell-Derived Brain Organoids
    • 13.3.5. Advancing Precision Medicine with Launch of a State-of-the-Art Organoid Facility for Next-Generation Disease Modeling
    • 13.3.6. Roche's Revolutionary Launch: The Institute of Human Biology to Propel Medical Research with Organoid Technology
    • 13.3.7. Roche Launches Institute of Human Biology in Basel to Revolutionize Drug Discovery with Organoid and Human Model System Research
    • 13.3.8. New Frontiers by National Science Foundation's Directorate for Engineering: From Organoid Intelligence to Tailored Learning
    • 13.3.9. Molecular Devices Partners with HUB Organoids to Advance 3D Biology Technologies
    • 13.3.10. Innovating Drug Discovery: Molecular Devices and HUB Organoids Forge Strategic Partnership

Companies Mentioned

  • 1. 3Dnamics Inc.
  • 2. AIVITA Biomedical, Inc.
  • 3. BICO Group AB
  • 4. Bio-Techne Corporation
  • 5. BioIVT LLC
  • 6. BrainZell
  • 7. Cannex Scientific, Inc.
  • 8. CN Bio Innovations Limited
  • 9. Corning Incorporated
  • 10. DefiniGEN Limited
  • 11. F. Hoffmann-La Roche Ltd.
  • 12. HeartBeat.bio AG
  • 13. Herophilus
  • 14. HUB Organoids B.V.
  • 15. InSphero AG
  • 16. Kirkstall Ltd.
  • 17. Merck KGaA
  • 18. Miltenyi Biotec B.V. & CO. KG
  • 19. Mimetas BV
  • 20. Molecular Devices, LLC by Danaher Corporation
  • 21. Neurxstem Inc.
  • 22. Organovo Holdings Inc.
  • 23. Pandorum Technologies Pvt. Ltd.
  • 24. PerkinElmer, Inc.
  • 25. PRIMACYT Cell Culture Technology GmbH
  • 26. Rumi Scientific, Inc.
  • 27. STEMCELL Technologies Canada Inc.
  • 28. SUN bioscience SA.
  • 29. Takara Holdings Inc.
  • 30. Thermo Fisher Scientific Inc.
  • 31. ZenBio, Inc.

LIST OF FIGURES

  • FIGURE 1. HUMAN ORGANOIDS MARKET RESEARCH PROCESS
  • FIGURE 2. HUMAN ORGANOIDS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL HUMAN ORGANOIDS MARKET SIZE, 2018-2030 (USD THOUSAND)
  • FIGURE 4. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 5. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 6. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 8. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 10. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 12. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 14. AMERICAS HUMAN ORGANOIDS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS HUMAN ORGANOIDS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 16. UNITED STATES HUMAN ORGANOIDS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES HUMAN ORGANOIDS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 18. ASIA-PACIFIC HUMAN ORGANOIDS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC HUMAN ORGANOIDS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA HUMAN ORGANOIDS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA HUMAN ORGANOIDS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD THOUSAND)
  • FIGURE 22. HUMAN ORGANOIDS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. HUMAN ORGANOIDS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. HUMAN ORGANOIDS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL HUMAN ORGANOIDS MARKET SIZE, 2018-2030 (USD THOUSAND)
  • TABLE 4. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 5. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
  • TABLE 6. HUMAN ORGANOIDS MARKET DYNAMICS
  • TABLE 7. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 8. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY COLORECTAL, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 9. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY HEART, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 10. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY KIDNEY, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 11. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY LIVER, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 12. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY PANCREAS, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 13. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
  • TABLE 14. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY CUSTOMIZABLE PRODUCTS, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 15. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY READY TO USE PRODUCTS, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 16. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 17. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY DEVELOPMENTAL BIOLOGY, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 18. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY DISEASE PATHOLOGY, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 19. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY DRUG TOXICITY & EFFICACY TESTING, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 20. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY PERSONALIZED MEDICINE, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 21. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY REGENERATIVE MEDICINE, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 22. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 23. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 24. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY CLINICAL RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 25. GLOBAL HUMAN ORGANOIDS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD THOUSAND)
  • TABLE 26. AMERICAS HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 27. AMERICAS HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
  • TABLE 28. AMERICAS HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 29. AMERICAS HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 30. AMERICAS HUMAN ORGANOIDS MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
  • TABLE 31. ARGENTINA HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 32. ARGENTINA HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
  • TABLE 33. ARGENTINA HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 34. ARGENTINA HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 35. BRAZIL HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 36. BRAZIL HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
  • TABLE 37. BRAZIL HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 38. BRAZIL HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 39. CANADA HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 40. CANADA HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
  • TABLE 41. CANADA HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 42. CANADA HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 43. MEXICO HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 44. MEXICO HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
  • TABLE 45. MEXICO HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 46. MEXICO HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 47. UNITED STATES HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 48. UNITED STATES HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
  • TABLE 49. UNITED STATES HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 50. UNITED STATES HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 51. UNITED STATES HUMAN ORGANOIDS MARKET SIZE, BY STATE, 2018-2030 (USD THOUSAND)
  • TABLE 52. ASIA-PACIFIC HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 53. ASIA-PACIFIC HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
  • TABLE 54. ASIA-PACIFIC HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 55. ASIA-PACIFIC HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 56. ASIA-PACIFIC HUMAN ORGANOIDS MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
  • TABLE 57. AUSTRALIA HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 58. AUSTRALIA HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
  • TABLE 59. AUSTRALIA HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 60. AUSTRALIA HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 61. CHINA HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 62. CHINA HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
  • TABLE 63. CHINA HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 64. CHINA HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 65. INDIA HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 66. INDIA HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
  • TABLE 67. INDIA HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 68. INDIA HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 69. INDONESIA HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 70. INDONESIA HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
  • TABLE 71. INDONESIA HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 72. INDONESIA HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 73. JAPAN HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 74. JAPAN HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
  • TABLE 75. JAPAN HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 76. JAPAN HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 77. MALAYSIA HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 78. MALAYSIA HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
  • TABLE 79. MALAYSIA HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 80. MALAYSIA HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 81. PHILIPPINES HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 82. PHILIPPINES HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
  • TABLE 83. PHILIPPINES HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 84. PHILIPPINES HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 85. SINGAPORE HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 86. SINGAPORE HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
  • TABLE 87. SINGAPORE HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 88. SINGAPORE HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 89. SOUTH KOREA HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 90. SOUTH KOREA HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
  • TABLE 91. SOUTH KOREA HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 92. SOUTH KOREA HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 93. TAIWAN HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 94. TAIWAN HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
  • TABLE 95. TAIWAN HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 96. TAIWAN HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 97. THAILAND HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 98. THAILAND HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
  • TABLE 99. THAILAND HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 100. THAILAND HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 101. VIETNAM HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 102. VIETNAM HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
  • TABLE 103. VIETNAM HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 104. VIETNAM HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
  • TABLE 107. EUROPE, MIDDLE EAST & AFRICA HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA HUMAN ORGANOIDS MARKET SIZE, BY COUNTRY, 2018-2030 (USD THOUSAND)
  • TABLE 110. DENMARK HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 111. DENMARK HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
  • TABLE 112. DENMARK HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 113. DENMARK HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 114. EGYPT HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 115. EGYPT HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
  • TABLE 116. EGYPT HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 117. EGYPT HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 118. FINLAND HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 119. FINLAND HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
  • TABLE 120. FINLAND HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 121. FINLAND HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 122. FRANCE HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 123. FRANCE HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
  • TABLE 124. FRANCE HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 125. FRANCE HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 126. GERMANY HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 127. GERMANY HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
  • TABLE 128. GERMANY HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 129. GERMANY HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 130. ISRAEL HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 131. ISRAEL HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
  • TABLE 132. ISRAEL HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 133. ISRAEL HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 134. ITALY HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 135. ITALY HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
  • TABLE 136. ITALY HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 137. ITALY HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 138. NETHERLANDS HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 139. NETHERLANDS HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
  • TABLE 140. NETHERLANDS HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 141. NETHERLANDS HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 142. NIGERIA HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 143. NIGERIA HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
  • TABLE 144. NIGERIA HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 145. NIGERIA HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 146. NORWAY HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 147. NORWAY HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
  • TABLE 148. NORWAY HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 149. NORWAY HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 150. POLAND HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 151. POLAND HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
  • TABLE 152. POLAND HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 153. POLAND HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 154. QATAR HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 155. QATAR HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
  • TABLE 156. QATAR HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 157. QATAR HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 158. RUSSIA HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 159. RUSSIA HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
  • TABLE 160. RUSSIA HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 161. RUSSIA HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 162. SAUDI ARABIA HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 163. SAUDI ARABIA HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
  • TABLE 164. SAUDI ARABIA HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 165. SAUDI ARABIA HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 166. SOUTH AFRICA HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 167. SOUTH AFRICA HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
  • TABLE 168. SOUTH AFRICA HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 169. SOUTH AFRICA HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 170. SPAIN HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 171. SPAIN HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
  • TABLE 172. SPAIN HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 173. SPAIN HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 174. SWEDEN HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 175. SWEDEN HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
  • TABLE 176. SWEDEN HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 177. SWEDEN HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 178. SWITZERLAND HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 179. SWITZERLAND HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
  • TABLE 180. SWITZERLAND HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 181. SWITZERLAND HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 182. TURKEY HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 183. TURKEY HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
  • TABLE 184. TURKEY HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 185. TURKEY HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 186. UNITED ARAB EMIRATES HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 187. UNITED ARAB EMIRATES HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
  • TABLE 188. UNITED ARAB EMIRATES HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 189. UNITED ARAB EMIRATES HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 190. UNITED KINGDOM HUMAN ORGANOIDS MARKET SIZE, BY PRODUCT, 2018-2030 (USD THOUSAND)
  • TABLE 191. UNITED KINGDOM HUMAN ORGANOIDS MARKET SIZE, BY USABILITY, 2018-2030 (USD THOUSAND)
  • TABLE 192. UNITED KINGDOM HUMAN ORGANOIDS MARKET SIZE, BY APPLICATION, 2018-2030 (USD THOUSAND)
  • TABLE 193. UNITED KINGDOM HUMAN ORGANOIDS MARKET SIZE, BY END-USER, 2018-2030 (USD THOUSAND)
  • TABLE 194. HUMAN ORGANOIDS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 195. HUMAN ORGANOIDS MARKET, FPNV POSITIONING MATRIX, 2023